• Something wrong with this record ?

Durability of Pulmonary Vein Isolation with Cryoballoon Ablation: Results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study

VY. Reddy, L. Sediva, J. Petru, J. Skoda, M. Chovanec, Z. Chitovova, P. Di Stefano, E. Rubin, S. Dukkipati, P. Neuzil,

. 2015 ; 26 (5) : 493-500. [pub] 20150415

Language English Country United States

Document type Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16010590

INTRODUCTION: Pulmonary vein (PV) reconnection remains the most important cause of AF recurrence after AF ablation. The second-generation cryoballoon catheter's ability to achieve durable PV isolation was assessed in a prospective nonrandomized clinical trial. METHODS AND RESULTS: PV isolation was performed by 4-minute ablations. Following verification of electrical isolation by a multielectrode mapping catheter, 1 additional lesion per PV was applied. Esophageal temperatures were monitored and all patients underwent postprocedure esophageal endoscopy. All patients underwent a second PV remapping procedure at ∼3 months to assess for PVI durability. Eighty-four (100%) veins were acutely isolated using only the 28 mm cryoballoon in 21 consecutive PAF patients with 2.2 ± 0.6 cryoapplications per vein, with the majority (83%) occurring after a single freeze. One patient presented with hematemesis and an esophageal ulceration that was treated conservatively; there were no episodes of esophageal fistula or phrenic nerve palsy. At 3.4 (2.9-4.1) months postablation, 68/75 veins (91%) remained electrically isolated; all PVs remained durably isolated in 79% of patients. Two patients accounted for 5 of 7 reconducting veins. The most common site for reconnection was the inferior aspect of the RIPV (3/7 reconnections). Reconnected veins had poorer occlusion at the index ablation procedure than veins that maintained chronic isolation (occlusion grade 2.9 ± 0.7 vs. 3.4 ± 0.7, P = 0.001). Clinical AF recurrence was detected in 2 patients (11%) at follow-up. CONCLUSIONS: The improved thermodynamic characteristics of the second-generation cryoballoon led to a high rate of both single-shot PVI and chronic lesion durability. This high rate of durable PV isolation is anticipated to translate to improved clinical outcome.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010590
003      
CZ-PrNML
005      
20160414121308.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jce.12626 $2 doi
024    7_
$a 10.1111/jce.12626 $2 doi
035    __
$a (PubMed)25644659
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Reddy, Vivek Y $u Cardiac Arrhythmia Service of the Mt. Sinai Hospital, New York, New York, USA.
245    10
$a Durability of Pulmonary Vein Isolation with Cryoballoon Ablation: Results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study / $c VY. Reddy, L. Sediva, J. Petru, J. Skoda, M. Chovanec, Z. Chitovova, P. Di Stefano, E. Rubin, S. Dukkipati, P. Neuzil,
520    9_
$a INTRODUCTION: Pulmonary vein (PV) reconnection remains the most important cause of AF recurrence after AF ablation. The second-generation cryoballoon catheter's ability to achieve durable PV isolation was assessed in a prospective nonrandomized clinical trial. METHODS AND RESULTS: PV isolation was performed by 4-minute ablations. Following verification of electrical isolation by a multielectrode mapping catheter, 1 additional lesion per PV was applied. Esophageal temperatures were monitored and all patients underwent postprocedure esophageal endoscopy. All patients underwent a second PV remapping procedure at ∼3 months to assess for PVI durability. Eighty-four (100%) veins were acutely isolated using only the 28 mm cryoballoon in 21 consecutive PAF patients with 2.2 ± 0.6 cryoapplications per vein, with the majority (83%) occurring after a single freeze. One patient presented with hematemesis and an esophageal ulceration that was treated conservatively; there were no episodes of esophageal fistula or phrenic nerve palsy. At 3.4 (2.9-4.1) months postablation, 68/75 veins (91%) remained electrically isolated; all PVs remained durably isolated in 79% of patients. Two patients accounted for 5 of 7 reconducting veins. The most common site for reconnection was the inferior aspect of the RIPV (3/7 reconnections). Reconnected veins had poorer occlusion at the index ablation procedure than veins that maintained chronic isolation (occlusion grade 2.9 ± 0.7 vs. 3.4 ± 0.7, P = 0.001). Clinical AF recurrence was detected in 2 patients (11%) at follow-up. CONCLUSIONS: The improved thermodynamic characteristics of the second-generation cryoballoon led to a high rate of both single-shot PVI and chronic lesion durability. This high rate of durable PV isolation is anticipated to translate to improved clinical outcome.
650    _2
$a akční potenciály $7 D000200
650    _2
$a senioři $7 D000368
650    _2
$a fibrilace síní $x diagnóza $x patofyziologie $x chirurgie $7 D001281
650    12
$a srdeční katétry $7 D062906
650    _2
$a kryochirurgie $x škodlivé účinky $x přístrojové vybavení $7 D003452
650    _2
$a elektrofyziologické techniky kardiologické $7 D022062
650    _2
$a design vybavení $7 D004867
650    _2
$a ezofágoskopie $7 D004945
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nerandomizované kontrolované studie jako téma $7 D065228
650    _2
$a prospektivní studie $7 D011446
650    _2
$a venae pulmonales $x patofyziologie $x chirurgie $7 D011667
650    _2
$a recidiva $7 D012008
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Česká republika $7 D018153
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Sediva, Lucie $u Homolka Hospital, Prague, Czech Republic.
700    1_
$a Petru, Jan $u Homolka Hospital, Prague, Czech Republic.
700    1_
$a Skoda, Jan $u Homolka Hospital, Prague, Czech Republic.
700    1_
$a Chovanec, Milan $u Homolka Hospital, Prague, Czech Republic.
700    1_
$a Chitovova, Zita $u Homolka Hospital, Prague, Czech Republic.
700    1_
$a Di Stefano, Paola $u EMEA Regional Clinical Center, Medtronic Clinical Research Institute, Milan, Italy.
700    1_
$a Rubin, Ethel $u Medtronic Inc., Minneapolis, Minnesota, USA.
700    1_
$a Dukkipati, Srinivas $u Cardiac Arrhythmia Service of the Mt. Sinai Hospital, New York, New York, USA.
700    1_
$a Neuzil, Petr $u Homolka Hospital, Prague, Czech Republic.
773    0_
$w MED00002569 $t Journal of cardiovascular electrophysiology $x 1540-8167 $g Roč. 26, č. 5 (2015), s. 493-500
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25644659 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160414121352 $b ABA008
999    __
$a ok $b bmc $g 1114019 $s 934958
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 26 $c 5 $d 493-500 $e 20150415 $i 1540-8167 $m Journal of cardiovascular electrophysiology $n J Cardiovasc Electrophysiol $x MED00002569
LZP    __
$a Pubmed-20160408
Back

Find record

Citation metrics

Archiving options